Ilium Mobilization in Patellofemoral Pain Syndrome Treatment

January 23, 2023 updated by: Labib Mousa Labib Ghali, Cairo University

Efficacy of Adding Posterior Ilium Mobilization to Treatment of Patellofemoral Pain Syndrome

Aim of the study is to investigate the effect of adding posterior ilium mobilization on knee pain, knee function, anterior pelvic tilt, dynamic knee valgus, muscle strength of extensors, abductors and external rotators of hip and knee extensors in patients with patellofemoral pain syndrome.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Giza, Egypt
        • Recruiting
        • Faculty of physical therapy, Cairo University
        • Contact:
        • Principal Investigator:
          • Labib M Ghali, MSc

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Age of the subjects between 18-35 years.
  2. BMI will be ≤ 29.5
  3. Anterior or retro patellar knee pain for at least 6 weeks duration.
  4. Foot posture index score from +6 to +12.
  5. Anterior pelvic tilt angle more than 8 degree.
  6. Pain elicited at least by two of the following four tests; (i) Isometric muscle contraction with slight bent knee,(ii) palpation of the patellofemoral joint line, (iii) patellar compression against the femoral bone (iv) active resisted knee extension.
  7. Pain intensity more than 3 at ANPS and provoked by at least two of the following activities: running, walking, hopping, squatting, stair negotiation, kneeling, or prolonged sitting.

Exclusion Criteria:

  1. Meniscal or other intraarticular pathologic conditions; cruciate or collateral ligament involvement.
  2. A history of traumatic patellar subluxation or dislocation.
  3. Previous surgery in the knee, ankle and hip joints.
  4. Knee, ankle and hip joints osteoarthritis.
  5. Taking non-steroidal anti-inflammatory drugs or corticosteroids within 24 h before the test.
  6. History of brain injury or vestibular disorder within the last 6 months.
  7. Pregnant female.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group 1
the participants will receive strengthening exercises on the hip and knee joint beside that they will receive stretching exercises
Experimental: Group 2
the participants will receive strengthening exercises on the hip and knee joint beside that they will receive stretching exercises
the therapist will mobilize the innominate on the affected side posteriorly

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in pain
Time Frame: It will be assessed at baseline and after 4 weeks
Arabic Numeric pain scale (ANPS) will be used to assess pain changes during walking, hopping, squatting, stair negotiation, kneeling, or prolonged sitting.
It will be assessed at baseline and after 4 weeks
Changes in knee functional disability
Time Frame: It will be assessed at baseline and after 4 weeks
The Arabic version of Anterior knee pain scale (AKPS) will be used to assess the knee functional disability
It will be assessed at baseline and after 4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in hip abductors strength
Time Frame: It will be assessed at baseline and after 4 weeks
Handheld dynamometer will be used to assess changes in muscle strength
It will be assessed at baseline and after 4 weeks
Changes in hip extensors strength
Time Frame: It will be assessed at baseline and after 4 weeks
Handheld dynamometer will be used to assess changes in muscle strength
It will be assessed at baseline and after 4 weeks
Changes in hip external rotators strength
Time Frame: It will be assessed at baseline and after 4 weeks
Handheld dynamometer will be used to assess changes in muscle strength
It will be assessed at baseline and after 4 weeks
Changes in knee extensors strength
Time Frame: It will be assessed at baseline and after 4 weeks
Handheld dynamometer will be used to assess changes in muscle strength
It will be assessed at baseline and after 4 weeks
Changes in dynamic knee valgus
Time Frame: It will be assessed at baseline and after 4 weeks
Cell phone Camera, tripod device and Kinovea Computer Program (KCP) will be used to assess knee frontal plane projection angle to detect changes in knee valgus during step down test
It will be assessed at baseline and after 4 weeks
Changes in pelvic tilt angle
Time Frame: It will be assessed at baseline and after 4 weeks
Palpation Meter (PALM) will be used to assess changes in pelvic tilt angle
It will be assessed at baseline and after 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

February 1, 2023

Primary Completion (Anticipated)

November 1, 2023

Study Completion (Anticipated)

December 1, 2023

Study Registration Dates

First Submitted

January 23, 2023

First Submitted That Met QC Criteria

January 23, 2023

First Posted (Actual)

February 1, 2023

Study Record Updates

Last Update Posted (Actual)

February 1, 2023

Last Update Submitted That Met QC Criteria

January 23, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patellofemoral Pain Syndrome

Clinical Trials on strengthening and stretching exercises

3
Subscribe